REVENUES (Tables)

9 Months Ended

Sep. 30, 2022

REVENUES

Schedule of operating lease revenue

	Third Quarter Ended				Nine Months Ended
	September 30				September 30
(millions)	2022		2021		2022		2021
Operating lease revenue*		$118.1		$103.3		$345.4		$306.4

Schedule of principal activities, separated by reportable segments and geographic region

Net sales at public exchange rates by reportable segment are as follows:

	Third Quarter Ended				Nine Months Ended
	September 30				September 30
(millions)	2022		2021		2022		2021
Global Industrial
Product and sold equipment		$1,551.8		$1,386.0		$4,381.6		$3,941.0
Service and lease equipment		217.8		217.1		643.6		637.6
Global Institutional & Specialty
Product and sold equipment		964.0		889.9		2,722.8		2,397.7
Service and lease equipment		199.1		180.7		574.5		506.3
Global Healthcare & Life Sciences
Product and sold equipment		329.5		259.4		1,023.7		795.4
Service and lease equipment		27.1		27.5		86.6		86.0
Other
Product and sold equipment		90.0		82.7		249.5		224.0
Service and lease equipment		262.3		241.5		737.9		676.4
Corporate
Product and sold equipment		27.7		35.8		96.3		103.5
Service and lease equipment		-		0.2		0.1		0.6
Total
Total product and sold equipment		$2,963.0		$2,653.8		$8,473.9		$7,461.6
Total service and lease equipment		$706.3		$667.0		$2,042.7		$1,906.9

Net sales at public exchange rates by geographic region for the third quarter ended September 30 are as follows:

	Global				Global Institutional				Global Healthcare
	Industrial				& Specialty				& Life Sciences				Other				Corporate
(millions)	2022		2021		2022		2021		2022		2021		2022		2021		2022		2021
North America		$836.4		$716.8		$860.5		$776.4		$146.8		$112.6		$227.1		$201.3		$24.8		$25.7
Europe		350.3		353.3		162.8		166.3		164.9		154.1		70.0		70.6		0.7		0.8
Asia Pacific		207.2		199.8		53.5		48.4		23.0		14.8		19.6		17.1		1.1		1.5
Latin America		160.6		141.0		40.8		34.9		5.9		-		12.9		13.0		1.1		6.7
Greater China		101.0		102.9		30.6		32.6		11.9		1.8		20.0		19.5		-		0.7
India, Middle East and Africa		114.1		89.3		14.9		12.0		4.1		3.6		2.7		2.7		-		0.6
Total		$1,769.6		$1,603.1		$1,163.1		$1,070.6		$356.6		$286.9		$352.3		$324.2		$27.7		$36.0

Net sales at public exchange rates by geographic region for the nine months ended September 30 are as follows:

	Global				Global Institutional				Global Healthcare
	Industrial				& Specialty				& Life Sciences				Other				Corporate
(millions)	2022		2021		2022		2021		2022		2021		2022		2021		2022		2021
North America		$2,329.6		$2,046.0		$2,420.6		$2,133.6		$449.5		$320.0		$623.7		$549.8		$84.5		$73.4
Europe		1,005.1		1,008.5		463.8		394.5		523.0		500.8		201.8		191.3		2.2		2.6
Asia Pacific		621.3		586.8		159.2		150.0		66.0		40.3		55.8		54.9		3.2		4.2
Latin America		453.0		400.5		119.1		97.3		16.2		1.1		39.0		37.7		6.2		19.4
Greater China		317.7		292.7		95.0		98.7		41.6		4.5		59.1		57.7		0.1		1.9
India, Middle East and Africa		298.5		244.1		39.6		29.9		14.0		14.7		8.0		9.0		0.2		2.6
Total		$5,025.2		$4,578.6		$3,297.3		$2,904.0		$1,110.3		$881.4		$987.4		$900.4		$96.4		$104.1

Summarized activity in the allowance for doubtful accounts

	Nine Months Ended
	September 30
(millions)	2022		2021
Beginning balance		$52.8		$68.4
Bad debt expense		26.8		12.4
Write-offs		(12.8)		(23.7)
Other (a)		2.1		(1.1)
Ending balance		$68.9		$56.0

(a) Other amounts are primarily the effects of changes in currency translations.

Schedule of contract liability

	Nine Months Ended
	September 30
(millions)	2022		2021
Contract liability as of beginning of the year		$91.7		$80.4
Revenue recognized in the period from:
Amounts included in the contract liability at the beginning of the year		(91.7)		(80.4)
Increases due to billings excluding amounts recognized as revenue during the period ended		109.1		86.7
Contract liability as of end of period		$109.1		$86.7